SEC Filing Details

SEC Filing Details

Document Details

Form
3
Filing Date
Apr 12, 2023
Document Date
Apr 10, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Chinook Therapeutics, Inc.
Issuer
CHINOOK THERAPEUTICS, INC.
Filer
Azelby Robert

IR Contact

Noopur Liffick

Senior Vice President
Investor Relations & Corporate Communications
investors@chinooktx.com

MEDIA CONTACT

Kelly North

Senior Manager
Investor Relations & Corporate Communications
media@chinooktx.com